BioCentury
ARTICLE | Clinical News

TriN 2755: Interim Phase I data

April 18, 2011 7:00 AM UTC

Interim data from 17 evaluable patients in an ongoing, open-label, dose-escalation, German Phase I trial showed that once-monthly IV TriN 2755 produced 4 cases of stable disease. In 3 evaluable patien...